ArticleBMC genomics2004
Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays.
Article in BMC genomics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Quantification of DNA through the NanoDrop Spectrophotometer: Methodological Validation Using Standard Reference Material and Sprague Dawley Rat and Human DNA.International journal of analytical chemistry · 2020Article
- Genomic-Wide Analysis with Microarrays in Human Oncology.Microarrays (Basel, Switzerland) · 2015Review
- Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model.Oncogene · 2013Article
- Article
- A new normalizing algorithm for BAC CGH arrays with quality control metrics.Journal of biomedicine & biotechnology · 2011Article
- Article
- Article
- Technical demonstration of whole genome array comparative genomic hybridization.Journal of visualized experiments : JoVE · 2008Article
- DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers.Oncogene · 2008Article
- Article
- Cytogenetically balanced translocations are associated with focal copy number alterations.Human genetics · 2007Article
- Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer.British journal of cancer · 2006Article
- Comprehensive copy number profiles of breast cancer cell model genomes.Breast cancer research : BCR · 2006Article
- A stepwise framework for the normalization of array CGH data.BMC bioinformatics · 2005Article
- NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.Oncogene · 2005Article
- Article
- Genetic alteration and gene expression modulation during cancer progression.Molecular cancer · 2004Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe recent development of array based comparative genomic hybridization (CGH) technology provides improved resolution for detection of genomic DNA copy number alterations. In array CGH, generating spotting solution is a multi-step process where bacterial artificial chromosome (BAC) clones are converted to replenishable PCR amplified fragments pools (AFP) for use as spotting solution in a microarray format on glass substrate. With completion of the human and mouse genome sequencing, large BAC clone sets providing complete genome coverage are available for construction of whole genome BAC arrays. Currently, Southern hybridization, fluorescent in-situ hybridization (FISH), and BAC end sequencing methods are commonly used to identify the initial BAC clone but not the end product used for spotting arrays. The AFP sequencing technique described in this study is a novel method designed to verify the identity of array spotting solution in a high throughput manner.
resultsWe show here that Southern hybridization, FISH, and AFP sequencing can be used to verify the identity of final spotting solutions using less than 10% of the AFP product. Single pass AFP sequencing identified over half of the 960 AFPs analyzed. Moreover, using two vector primers approximately 90% of the AFP spotting solutions can be identified.
conclusionsIn this feasibility study we demonstrate that current methods for identifying initial BAC clones can be adapted to verify the identity of AFP spotting solutions used in printing arrays. Of these methods, AFP sequencing proves to be the most efficient for large scale identification of spotting solution in a high throughput manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.